NCT05028686 Predicting Readmissions Using Omics, Biostatistical Evaluate and Artificial Intelligence
| NCT ID | NCT05028686 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institute for Clinical Evaluative Sciences |
| Condition | Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2019-02-01 |
| Primary Completion | 2024-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2019-02-01 with a primary completion date of 2024-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a prospective registry that aims to predict readmissions in patients with heart failure, using -omics, machine learning, patient reported outcomes, clinical data and other high-dimensional data sources.
Eligibility Criteria
Inclusion Criteria: * Any patient aged 18 years or older admitted to hospital or seen in the emergency department with heart failure defined clinically * The diagnosis will be guided by the Framingham criteria for HF and/or BNP. A BNP \>400 will be defined as definite heart failure and BNP 100-400 classified as possible heart failure. * Provides informed consent Exclusion Criteria: * Patients who cannot communicate due to dementia or severe cognitive deficits * non-Ontario residents * nursing home residents * those who are not discharged home but are discharged to a skilled nursing facility (long-term care or chronic institution) * those who are unable to communicate who do not have a proxy (e.g. spouse or close family member) to facilitate communication with the patient.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05028686 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 105 Years, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05028686 currently recruiting?
Yes, NCT05028686 is actively recruiting participants. Contact the research team at dlee@ices.on.ca for enrollment information.
Where is the NCT05028686 trial being conducted?
This trial is being conducted at Toronto, Canada.
Who is sponsoring the NCT05028686 clinical trial?
NCT05028686 is sponsored by Institute for Clinical Evaluative Sciences. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.